Zymeworks, Inc. (ZYME)
Zymeworks Market Cap : 1.806B for Nov. 18, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 17, 2026 | 1.853B |
| November 16, 2026 | 1.897B |
| November 13, 2026 | 1.882B |
| November 12, 2026 | 1.898B |
| November 11, 2026 | 2.085B |
| November 10, 2026 | 2.256B |
| November 09, 2026 | 2.210B |
| November 06, 2026 | 2.125B |
| November 05, 2026 | 2.061B |
| November 04, 2026 | 2.227B |
| November 03, 2026 | 2.168B |
| November 02, 2026 | 2.086B |
| October 30, 2026 | 2.059B |
| October 29, 2026 | 2.066B |
| October 28, 2026 | 2.080B |
| October 27, 2026 | 2.076B |
| October 26, 2026 | 2.042B |
| October 23, 2026 | 2.031B |
| October 22, 2026 | 2.047B |
| October 21, 2026 | 2.023B |
| October 20, 2026 | 1.937B |
| October 19, 2026 | 1.838B |
| October 16, 2026 | 1.801B |
| October 15, 2026 | 1.853B |
| October 14, 2026 | 1.783B |
| Date | Value |
|---|---|
| October 13, 2026 | 1.804B |
| October 12, 2026 | 1.823B |
| October 09, 2026 | 1.856B |
| October 08, 2026 | 1.818B |
| October 07, 2026 | 1.909B |
| October 06, 2026 | 1.846B |
| October 05, 2026 | 1.886B |
| October 02, 2026 | 1.810B |
| October 01, 2026 | 1.868B |
| September 30, 2026 | 1.906B |
| September 29, 2026 | 1.957B |
| September 28, 2026 | 1.952B |
| September 25, 2026 | 1.908B |
| September 24, 2026 | 1.929B |
| September 23, 2026 | 1.979B |
| September 22, 2026 | 1.984B |
| September 21, 2026 | 1.929B |
| September 18, 2026 | 1.912B |
| September 17, 2026 | 1.978B |
| September 16, 2026 | 1.888B |
| September 15, 2026 | 1.875B |
| September 14, 2026 | 1.932B |
| September 11, 2026 | 1.888B |
| September 10, 2026 | 1.902B |
| September 09, 2026 | 1.954B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| AbbVie, Inc. | 509.33B |
| Faeth Therapeutics, Inc. | 228.70M |
| ACADIA Pharmaceuticals, Inc. | 3.145B |
| Alnylam Pharmaceuticals, Inc. | 20.40B |
| Anika Therapeutics, Inc. | 178.14M |
Market Cap Related Metrics
| PE Ratio | 48.22 |
| PS Ratio | 7.083 |
| Price to Book Value | 6.992 |
| Price | 25.18 |
| Earnings Yield | 2.07% |
| Operating PE Ratio | 42.67 |
| Normalized PE Ratio | 47.95 |